BlackRock’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$116K Sell
2022
Q2
$411K Buy
2022
Q1
$899K Sell
2021
Q4
$1.79M Buy
2021
Q3
$1.61M Buy
2021
Q2
$1.81M Sell
2021
Q1
$4.22M Buy
2020
Q4
$4.01M Buy
2020
Q3
$3.98M Buy
2020
Q2
$4.98M Buy
2020
Q1
$3.28M Sell
2019
Q4
$6.11M Buy
2019
Q3
$3.83M Buy
2019
Q2
$11.7M Buy
2019
Q1
$430K Buy
2018
Q4
$79K Buy